[hot spot]
Wanhua Chemical Group Co.Ltd(600309) : the listing price of pure MDI in China increased by
Wanhua Chemical Group Co.Ltd(600309) (600309) announced on February 25 that since March 2022, Wanhua Chemical Group Co.Ltd(600309) China’s aggregate MDI listing price is 22800 yuan / ton (no change compared with February); The listing price of pure MDI is 26800 yuan / ton (3000 yuan / ton higher than the price in February).
Aba Chemicals Corporation(300261) performance express: net profit in 2021 increased by 12.13% year-on-year
Aba Chemicals Corporation(300261) (300261) released the performance express on February 25. The operating revenue in 2021 was 2.085 billion yuan, a year-on-year increase of 4.09%; The net profit attributable to the parent company was 181 million yuan, a year-on-year increase of 12.13%; The basic earnings per share is 0.1891 yuan.
National Silicon Industry Group Co.Ltd(688126) fixed increase result: the large fund phase II was allocated about 1.5 billion yuan
National Silicon Industry Group Co.Ltd(688126) (688126) disclosed the fixed increase results. The total amount raised was about 5 billion yuan, of which the second phase of the large fund was allocated about 1.5 billion yuan.
China Evergrande: signed cooperation agreements with Everbright trust and Minmetals trust
China Evergrande announced that on February 25, the Group signed a cooperation agreement with Everbright trust and Minmetals trust on the sale of the group’s relevant equity in four projects to them. The trust institution will take over the operation and management of the project company, invest funds in the project company to ensure the subsequent development and construction of the project and guarantee the delivery of the building, and the group has the right to repurchase equity. Through this cooperation with trust institutions, the group can recover part of the early-stage investment of the project of about RMB 1.95 billion and resolve the debt involved in the project of about RMB 7.01 billion. The recovered investment has a positive impact on the guaranteed delivery and debt resolution of other projects of the group.
Shanghai Medicilon Inc(688202) performance express: net profit in 2021 increased by 117.93% year-on-year
Shanghai Medicilon Inc(688202) (688202) released the performance express on February 25. The operating revenue in 2021 was 1.167 billion yuan, a year-on-year increase of 75.27%; The net profit attributable to the parent company was 282 million yuan, a year-on-year increase of 117.93%; The basic earnings per share is 4.55 yuan. During the reporting period, benefiting from the increasing encouragement of national policies for the pharmaceutical industry and the continuous improvement of pharmaceutical enterprises’ investment in innovative drug R & D, while optimizing the business structure, the company firmly grasped the development opportunity of preclinical cro market, and the customer development ability and order acceptance ability were improved simultaneously.
Harbin Jiuzhou Group Co.Ltd(300040) performance express: the net profit in 2021 was 184 million yuan, with a year-on-year increase of 162.52%
Harbin Jiuzhou Group Co.Ltd(300040) (300040) released the performance express on February 25. The operating revenue in 2021 was 1.398 billion yuan, a year-on-year increase of 9.23%; The net profit attributable to the parent company was 184 million yuan, a year-on-year increase of 162.52%; The basic earnings per share is 0.33 yuan. The performance growth was mainly due to the growth of the company’s renewable energy business, the reversal of credit impairment losses caused by the inclusion of Ronghe power investment No. 1 (Jiaxing) venture capital partnership (limited partnership) into the scope of the company’s merger, and the increase of profits due to the sale of some equity of Merris comprehensive smart energy project.
Zhejiang Orient Gene Biotech Co.Ltd(688298) performance express: the net profit in 2021 was 4.777 billion yuan, with a year-on-year increase of 184.8%
Zhejiang Orient Gene Biotech Co.Ltd(688298) (688298) released the performance express on February 25. The operating revenue in 2021 was 10.032 billion yuan, a year-on-year increase of 207.22%; The net profit attributable to the parent company was 4.777 billion yuan, a year-on-year increase of 184.80%; The basic earnings per share is 39.81 yuan. In 2021, New Coronavirus rapid detection reagent (including family self testing) continued to be put into the epidemic prevention business. The sales performance of the products in the European market continued to increase significantly, and the routine diagnostic reagents and diagnostic instruments business maintained steady development, which contributed to a substantial increase in operating performance in 2021.
Ningbo Energy Group Co.Ltd(600982) : Recently, preliminary negotiations are being held with Fenghua district government on pumped storage projects
Ningbo Energy Group Co.Ltd(600982) (600982) the announcement of changes was issued on February 25. According to the company’s self-examination, the company is currently conducting preliminary negotiations with the people’s Government of Fenghua District, Ningbo and Power Construction Corporation Of China Ltd(Powerchina Ltd)(601669) Group East China survey, design and Research Institute Co., Ltd. on the cooperation of pumped storage projects in Fenghua area. The contents of the tripartite negotiations are not legally binding, and there are major uncertainties in the implementation of the project.
Asahi biological performance express: the net profit in 2021 was 739 million yuan, with a year-on-year increase of 13.82%
An Xu Biology (688075) released its performance express on February 25. The operating revenue in 2021 was 1.589 billion yuan, a year-on-year increase of 32.47%; The net profit attributable to the parent company was 739 million yuan, a year-on-year increase of 13.82%; The basic earnings per share is 15.62 yuan. During the reporting period, the company’s high-quality covid-19 testing product quality was recognized by the market and customers, the operating revenue and net profit increased rapidly, and the sales scale continued to expand.
[performance]
Guangdong Leadyo Ic Testing Co.Ltd(688135) performance express: net profit in 2021 increased by 114.12% year-on-year
Guangdong Leadyo Ic Testing Co.Ltd(688135) (688135) released the performance express on February 25. The operating revenue in 2021 was 398 million yuan, a year-on-year increase of 57.44%; The net profit attributable to the parent company was 111 million yuan, a year-on-year increase of 114.12%; The basic earnings per share is 0.82 yuan. With the gradual implementation of raised investment projects, the testing capacity is gradually released and benefits are generated. The company’s chip testing in 5g communication, industrial control, biometrics, MCU, aiot and other fields maintained rapid growth in 2021.
Cambricon Technologies Corporation Limited(688256) performance express: loss of 847 million yuan in 2021
Cambricon Technologies Corporation Limited(688256) (688256) released the performance express on February 25. The operating revenue in 2021 was 721 million yuan, a year-on-year increase of 57.12%; The net profit attributable to the parent company lost 847 million yuan, and the net profit attributable to the parent company lost 435 million yuan in the same period of last year; The basic earnings per share is -2.12 yuan. During the reporting period, the edge product line mlu220 chip and accelerator card landed in a number of head enterprises, achieved large-scale sales of nearly one million pieces during the reporting period, and the income of the edge product line achieved a breakthrough growth over the same period of last year. Relying on the benchmarking effect and excellent reputation of the company’s early projects, the company won the bid for the infrastructure construction project of Intelligent Computing Center in Kunshan, Jiangsu, and the revenue of cluster business increased significantly compared with the same period of last year.
Bloomage Biotechnology Corporation Limited(688363) performance express: net profit in 2021 increased by 21.13% year-on-year
Bloomage Biotechnology Corporation Limited(688363) (688363) released the performance express on February 25. The operating revenue in 2021 was 4.948 billion yuan, a year-on-year increase of 87.93%; The net profit attributable to the parent company was 782 million yuan, a year-on-year increase of 21.13%; The basic earnings per share is 1.63 yuan.
During the reporting period, the company steadily promoted the “four-wheel drive” business layout, the raw material business and medical terminal business grew steadily, the functional skin care business continued to maintain rapid growth, and the functional food business got a good start.
National Silicon Industry Group Co.Ltd(688126) performance express: net profit in 2021 increased by 66.58% year-on-year
National Silicon Industry Group Co.Ltd(688126) (688126) released the performance express on February 25. The operating revenue in 2021 was 2.467 billion yuan, a year-on-year increase of 36.19%; The net profit attributable to the parent company was 145 million yuan, a year-on-year increase of 66.58%; The basic earnings per share is 0.058 yuan. The company’s operating revenue in the reporting period increased by about 36.19% over the same period of last year due to the strong demand in the semiconductor market and the continuous rise of the company’s production capacity, with a significant increase in output and sales volume.
Shanghai Fudan Microelectronics Group Co.Ltd(688385) performance express: net profit in 2021 increased by 286.26% year-on-year
Shanghai Fudan Microelectronics Group Co.Ltd(688385) (688385) released the performance express on February 25. The operating revenue in 2021 was 2.576 billion yuan, a year-on-year increase of 52.37%; The net profit attributable to the parent company was 513 million yuan, a year-on-year increase of 286.26%; The basic earnings per share is 0.69 yuan. It is mainly due to the strong demand in the downstream application market of integrated circuits. The company seized the development opportunities of the industry, actively explored the market and new customers, optimized the product and customer structure, and achieved growth in the operating revenue of each product line. Benefiting from the introduction of new products and the increase of unit prices of some products, the comprehensive gross profit margin increased by 12.89 percentage points over the previous year.
Bgi Genomics Co.Ltd(300676) performance express: covid-19 business market competition intensifies, and the net profit in 2021 decreases by 31%
Bgi Genomics Co.Ltd(300676) (300676) disclosed the performance express of 2021 on February 25. During the reporting period, the company is expected to realize an operating revenue of 6.701 billion yuan, a decrease of 20.20% over the same period of last year; The net profit was 1.431 billion yuan, a decrease of 31.55% over the same period last year. During the reporting period, the company’s performance decreased compared with that in 2020, mainly due to the intensification of covid-19 business market competition, the decline of global covid-19 nucleic acid reagent and detection unit price, and the change of epidemic prevention strategy in some countries and regions. The company took the initiative to strategically adjust covid-19 related product structure and supply chain strategy, The profits related to covid-19 have decreased compared with the higher base in 2020.
Jingke energy performance express: the net profit in 2021 was 1.123 billion yuan, with a year-on-year increase of 7.82%
Jingke energy (688223) released a performance express on February 25. The operating revenue in 2021 was 40.480 billion yuan, a year-on-year increase of 20.26%; The net profit attributable to the parent company was 1.123 billion yuan, a year-on-year increase of 7.82%; The basic earnings per share is 0.14 yuan. During the reporting period, relying on the advantages of industry-leading global layout and continuous technological innovation, the company realized the steady growth of component shipments and the further increase of the proportion of large-size products, resulting in the steady growth of operating revenue and operating profit.
Cansino Biologics Inc(688185) performance express: year-on-year profit of 1.914 billion yuan in 2021
Cansino Biologics Inc(688185) – U (688185) released the performance express on February 25. The operating revenue in 2021 was 4.300 billion yuan, a year-on-year increase of 17174.54%; The net profit attributable to the parent company was 1.914 billion yuan, reversing losses year-on-year; The basic earnings per share is 7.74 yuan. The growth is mainly due to the restructuring of the New Coronavirus vaccine (type 5 adenovirus vector) (trade name: Ke Sha), which has been granted conditional listing approval and emergency use authorization in many countries in the world. The commercialization of the product has a positive impact on the company’s total revenue and related profit indicators.
Zhejiang Grandwall Electric Science&Technology Co.Ltd(603897) : the net profit in 2021 was 341 million yuan, with a year-on-year increase of 95.79%
Zhejiang Grandwall Electric Science&Technology Co.Ltd(603897) (603897) disclosed the annual report on February 25. The company achieved an operating revenue of 10.727 billion yuan in 2021, an increase of 70.99% year-on-year; The net profit attributable to the parent company was 341 million yuan, a year-on-year increase of 95.79%; The basic earnings per share is 1.89 yuan. It is proposed to distribute a cash dividend of 3 yuan (including tax) for every 10 shares.
Wuxi Etek Microelectronics Co.Ltd(688601) performance express: net profit in 2021 increased by 137.48% year-on-year
Wuxi Etek Microelectronics Co.Ltd(688601) (688601) released the performance express on February 25. The operating revenue in 2021 was 774 million yuan, a year-on-year increase of 42.63%; The net profit attributable to the parent company was 159 million yuan, a year-on-year increase of 137.48%; The basic earnings per share is 2.84 yuan. During the reporting period, the downstream demand of the company’s power management chip industry was strong. Based on its own advantages, the company realized the improvement of the original field and customer share and the introduction of new products. The company has been deeply engaged in the field of consumer electronics, actively exploring new markets and customers, and achieving better growth in sales scale and economic benefits.
Shandong Nanshan Aluminium Co.Ltd(600219) performance express: net profit in 2021 increased by 66.18% year-on-year
Shandong Nanshan Aluminium Co.Ltd(600219) (600219) released the performance express on February 25. The operating revenue in 2021 was 28.725 billion yuan, a year-on-year increase of 28.82%; The net profit attributable to the parent company was 3.406 billion yuan, a year-on-year increase of 66.18%; The basic earnings per share is 0.28 yuan. Thanks to the strong market demand brought by the downstream industry, the production and sales of the company’s automobile sector products were booming in 2021, with a significant increase over the same period last year, the sales volume exceeded 110000 tons, and the overall profit increased significantly. With the significant increase in the production and sales of automobile sectors, the company further consolidated its position as a leading enterprise in China’s automobile sectors.
Daan Gene Co.Ltd(002030) performance express: the net profit in 2021 was 3.592 billion yuan, with a year-on-year increase of 46.67%
Daan Gene Co.Ltd(002030) (002030) released the performance express on February 25. The operating revenue in 2021 was 7.634 billion yuan, a year-on-year increase of 42.92%; The net profit attributable to the parent company was 3.592 billion yuan, a year-on-year increase of 46.67%; The basic earnings per share is 2.56 yuan. The company has independently developed, fully penetrated nucleic acid detection technology, the whole industry chain platform, launched sufficient capacity to provide New Coronavirus nucleic acid detection kit and nucleic acid detection equipment, related consumables, fully protect the market supply, help large-scale COVID-19 nucleic acid screening and nucleic acid detection work, has a positive impact on the company’s performance.
Beijing-Shanghai High Speed Railway Co.Ltd(601816) performance express: the net profit in 2021 was 4.815 billion yuan, with a year-on-year increase of 49.12%
Beijing-Shanghai High Speed Railway Co.Ltd(601816) (601816) released the performance express on February 25. The operating revenue in 2021 was 29.304 billion yuan, a year-on-year increase of 16.11%; The net profit attributable to the parent company was 4.815 billion yuan, a year-on-year increase of 49.12%; The basic earnings per share is 0.10 yuan. Due to the better situation of epidemic prevention and control year-on-year, the Feihu section of Hehang high-speed railway of the subsidiary Jingfu Anhui company was put into operation in June 2020. The passenger traffic volume and the number of trains of the company increased compared with the same period, and the corresponding passenger transportation service income and road network service income increased.
Shanghai International Airport Co.Ltd(600009) performance express: a loss of 1.711 billion yuan in 2021, with a year-on-year increase of
Shanghai International Airport Co.Ltd(600009) (600009) released the performance express on February 25. The operating revenue in 2021 was 3.728 billion yuan, a year-on-year decrease of 13.38%; The net profit attributable to the parent company was 1.711 billion yuan, and the net profit attributable to the parent company was 1.267 billion yuan in the same period of last year; The basic earnings per share is -0.89 yuan.
The company’s business development and customer operation are greatly impacted by the continuous impact of the epidemic, and the operation continues to be under pressure.
Suzhou Good-Ark Electronics Co.Ltd(002079) performance express: the net profit in 2021 was 220 million yuan, with a year-on-year increase of 143.38%
Suzhou Good-Ark Electronics Co.Ltd(002079) (002079) released the performance express on February 25. The operating revenue in 2021 was 2.636 billion yuan, a year-on-year increase of 46.07%; The net profit attributable to the parent company was 220 million yuan, a year-on-year increase of 143.38%; The basic earnings per share is 0.28 yuan. During the reporting period, the overall prosperity of the semiconductor industry was high, the domestic substitution of power semiconductors accelerated, the market share of automotive electronic products strategically deployed by the company in previous years continued to increase, the integrated circuit, ppak packaging and MEMS packaging and testing increased rapidly, and the sales and sales reached a new high.
Performance express of Hemai shares: the prosperity of photovoltaic industry continued to improve, and the net profit increased by 87% year-on-year in 2021
Hemai shares (688032) released a performance express on February 25. The operating revenue in 2021 was 782 million yuan, a year-on-year increase of 58.03%; The net profit attributable to the parent company was 195 million yuan, a year-on-year increase of 87.16%; The basic earnings per share is 6.49 yuan. In 2021, the prosperity of the global photovoltaic industry continued to improve. The company actively grasped the market opportunities and continuously strengthened the R & D and market development of new products, resulting in a significant increase in new orders signed by the company and a continuous increase in sales compared with last year. At the same time, with the significant improvement of the company’s capacity utilization and output in 2021, and the continuous optimization of product and customer structure, the resulting scale effect has significantly improved the company’s profitability.
Shanghai Junshi Biosciences Co.Ltd(688180) performance express: loss of 739 million yuan in 2021
Shanghai Junshi Biosciences Co.Ltd(688180) (688180) released the performance express on February 25. The operating revenue in 2021 was 4.014 billion yuan, a year-on-year increase of 151.71%; The net loss in the same period of last year was RMB 1.67 billion, which was attributable to the parent company and the net profit was RMB 1.67 billion; The basic earnings per share is -0.83 yuan. During the reporting period, the company’s operating revenue increased significantly, mainly due to the significant growth of technology licensing revenue, the increase of franchise revenue and the sales revenue brought by the commercialization of treprizumab injection (trade name: tuoyi) in the Chinese market.
Luoyang Jalon Micro-Nano New Materials Co.Ltd(688357) performance express: net profit in 2021 increased by 116.15% year-on-year
Luoyang Jalon Micro-Nano New Materials Co.Ltd(688357) (688357) released the performance express on February 25. The operating revenue in 2021 was 878 million yuan, a year-on-year increase of 94.36%; The net profit attributable to the parent company was 275 million yuan, a year-on-year increase of 116.15%; The basic earnings per share is 4.76 yuan. During the reporting period, with the gradual production of the company’s new production line and the steady release of new production capacity, it not only enriched the company’s product categories, but also improved the company’s market supply capacity and promoted the continuous growth of operating revenue.
Guoxin technology performance express: net profit in 2021 increased by 51.37% year-on-year
Guoxin Technology (688262) released its performance express on February 25. The operating revenue in 2021 was 407 million yuan, a year-on-year increase of 56.99%; The net profit attributable to the parent company was 69.2443 million yuan, a year-on-year increase of 51.37%; The basic earnings per share is 0.38 yuan. During the reporting period, the prosperity of semiconductor chip industry rebounded and customer demand increased. The scale effect brought by the company made the operating profit and net profit of the company grow rapidly.
Suzhou Nanomicro Technology Co.Ltd(688690) performance express: net profit in 2021 increased by 158.75% year-on-year
Suzhou Nanomicro Technology Co.Ltd(688690) (688690) released the performance express on February 25. The operating revenue in 2021 was 446 million yuan, a year-on-year increase of 117.74%; The net profit attributable to the parent company was 188 million yuan, a year-on-year increase of 158.75%; The basic earnings per share is 0.5 yuan. Relying on the innovative advantages of nano microsphere bottom preparation technology, the company has accumulated and formed a relatively complete product line, large-scale production capacity and professional and efficient application technology service capacity, which has supported the rapid growth of the company’s performance.
Pylon Technologies Co.Ltd(688063) performance express: net profit of RMB 316 million in 2021, with a year-on-year increase of 15%
Pylon Technologies Co.Ltd(688063) (688063) released the performance express on February 25. The operating revenue in 2021 was 2.063 billion yuan, a year-on-year increase of 84.21%; The net profit attributable to the parent company was 316 million yuan, a year-on-year increase of 15.00%; The basic earnings per share is 2.04 yuan. In 2021, the total sales volume of products was 1541mwh, with a year-on-year increase of 111.96%. The sharp increase of production and sales volume has led to the increase of total operating revenue.
Jiangsu Goodwe Power Supply Technology Co.Ltd(688390) performance express: the overall development trend of photovoltaic industry is good, and the net profit in 2021 increased by 8% year-on-year
Jiangsu Goodwe Power Supply Technology Co.Ltd(688390) (688390) released the performance express on February 25. The operating revenue in 2021 was 2.686 billion yuan, a year-on-year increase of 69.01%; The net profit attributable to the parent company was 281 million yuan, a year-on-year increase of 8.09%; The basic earnings per share is 3.20 yuan. During the reporting period, the overall development trend of the photovoltaic industry was good, and the demand for orders was strong. At the same time, the company continued to increase R & D investment and technological innovation, enrich product series, and the total operating revenue increased significantly compared with the same period last year.
Wuhan Keqian Biology Co.Ltd(688526) performance express: net profit of RMB 571 million in 2021, with a year-on-year increase of 27.47%
Wuhan Keqian Biology Co.Ltd(688526) (688526) released the performance express on February 25. The operating revenue in 2021 was 1.103 billion yuan, a year-on-year increase of 30.81%; The net profit attributable to the parent company was 571 million yuan, a year-on-year increase of 27.47%; The basic earnings per share is 1.23 yuan. During the reporting period, the business scale of customers expanded and the demand for pig vaccine increased significantly. The company seized the favorable opportunity of the market, actively explored the sales market, improved production efficiency, improved product quality and strengthened technical services, so as to continuously improve the recognition of products.
Shandong Sun Paper Co.Ltd(002078) performance express: the net profit in 2021 was 2.941 billion yuan, with a year-on-year increase of 50.56%
Shandong Sun Paper Co.Ltd(002078) (002078) released the performance express on February 25. The operating revenue in 2021 was 31.874 billion yuan, a year-on-year increase of 47.64%; The net profit attributable to the parent company was 2.941 billion yuan, a year-on-year increase of 50.56%; The basic earnings per share is 1.11 yuan. The performance growth was mainly due to the release of the company’s new production capacity and the increase in the production and sales of related paper products and wood pulp during the reporting period.
Performance express of No. 9 company: net profit in 2021 increased by 464.68% year-on-year
No. 9 company (689009) released its performance express on February 25. In 2021, the company achieved a total operating revenue of 9.127 billion yuan, a year-on-year increase of 52.04%; The net profit attributable to the parent company was 415 million yuan, a year-on-year increase of 464.68%. Intelligent electric scooters and other major products achieved steady growth year-on-year; At the same time, intelligent electric bicycles, intelligent electric motorcycles and all terrain vehicles have been put into the market and achieved good results, expanding new profit growth points.
Kbc Corporation Ltd(688598) : the net profit in 2021 was 501 million yuan, with a year-on-year increase of 197.25%
Kbc Corporation Ltd(688598) (688598) disclosed the annual report on February 25. The company achieved an operating revenue of 1.338 billion yuan in 2021, an increase of 213.72% year-on-year; The net profit attributable to the parent company was 501 million yuan, a year-on-year increase of 197.25%; The basic earnings per share is 6.26 yuan. A cash dividend of 2.5 yuan (including tax) will be distributed for every 10 shares.
Dongxin performance express: net profit in 2021 increased by 1240.81% year-on-year
Dongxin (688110) released its performance express on February 25. The operating revenue in 2021 was 1.139 billion yuan, a year-on-year increase of 45.28%; The net profit attributable to the parent company was 262 million yuan, a year-on-year increase of 1240.81%; The basic earnings per share is 0.77 yuan.
In 2021, the global semiconductor industry continues to recover, the overall prosperity of the industry is high, and the market demand corresponding to the company’s products is strong. With the continuous enrichment of the company’s product line and the gradual completion of the customer introduction period, the products are gradually in large quantities, the sales scale is gradually expanded, and the scale effect is gradually apparent. Among them, the growth of communication, industry and other fields is particularly obvious.
Beijing Huafeng Test & Control Technology Co.Ltd(688200) : the net profit in 2021 increased by 120% year-on-year, and it is proposed to pay 21.5 yuan for 10
Beijing Huafeng Test & Control Technology Co.Ltd(688200) (688200) announced on February 25 that the net profit in 2021 was 439 million yuan, a year-on-year increase of 120.28%; It is proposed to distribute 21.5 yuan in 10, with a total cash dividend of 132 million yuan.
Shanxi Zhendong Pharmaceutical Co.Ltd(300158) performance express: net profit in 2021 increased by 903% year-on-year
Shanxi Zhendong Pharmaceutical Co.Ltd(300158) (300158) released the performance express on February 25. The operating revenue in 2021 was 5.093 billion yuan, a year-on-year increase of 5.05%; The net profit attributable to the parent company was 2.629 billion yuan, a year-on-year increase of 903.37%; The basic earnings per share is 2.56 yuan. The main reason is the increase of monetary capital and undistributed profit due to the sale of Langdi pharmaceutical.
Wayz Intelligent Manufacturing Technology Co.Ltd(688211) performance express: the overall demand of the intelligent logistics equipment industry continued to be strong, and the net profit increased by 19% year-on-year in 2021
Wayz Intelligent Manufacturing Technology Co.Ltd(688211) (688211) released the performance express on February 25. The operating revenue in 2021 was 2.208 billion yuan, a year-on-year increase of 83.33%; The net profit attributable to the parent company was 254 million yuan, a year-on-year increase of 19.24%; The basic earnings per share is 2.44 yuan. During the reporting period, the overall demand of the intelligent logistics equipment industry continued to be strong, and the comprehensive advantages of the company as a leading enterprise in the industry further increased.
[increase / decrease]
Guangdong Tonze Electric Co.Ltd(002759) : the controlling shareholders and persons acting in concert intend to reduce their shares by no more than 4%
Guangdong Tonze Electric Co.Ltd(002759) (002759) announced on February 25 that the controlling shareholder and its person acting in concert, Xingjia international, plan to reduce their total holdings of no more than 16086100 shares of the company within 6 months from the date of disclosure of the announcement, accounting for 4% of the total share capital of the company.
Hongta Securities Co.Ltd(601236) : cloud Investment Group plans to reduce its shares by no more than 4%
Hongta Securities Co.Ltd(601236) (601236) announced on February 25 that the shareholder Yunnan Investment Holding Group Co., Ltd. (hereinafter referred to as “cloud investment group”) plans to reduce the total number of shares of the company by no more than 189 million shares, accounting for no more than 4% of the total shares of the company.
Rongan Property Co.Ltd(000517) : the general manager plans to increase his shareholding of no less than 20 million yuan
Rongan Property Co.Ltd(000517) (000517) announced on February 25 that Wang Congwei, the director and general manager, plans to increase his holding of shares by no less than 20 million yuan. On the same day, it was announced that Xinhai investment plans to reduce 10 million shares of the company (accounting for 0.31% of the total share capital of the company) due to its own business development and capital needs.
[Contract winning]
Sinopec Oilfield Service Corporation(600871) : newly signed overseas contracts of 3.87 billion yuan
Sinopec Oilfield Service Corporation(600871) (600871) announced on February 25 that the wholly-owned subsidiary China Petroleum & Chemical Corporation(600028) Group International Petroleum Engineering Co., Ltd. and total energy Uganda Co., Ltd. signed the main contract of Uganda tilenga oil and gas gathering and transportation system epscc project. The total construction period of the project is 76 months, and the contract amount is US $611 million. Tilenga block in Uganda contains 5 oil reservoirs and 31 cluster well pads (426 wells), with an annual output of about 10 million tons of crude oil. The above contracts are equivalent to about RMB 3.87 billion, accounting for about 5.69% of the company’s operating revenue in 2020 under Chinese accounting standards.
Ouma software: a fixed-point service project for scanning the answer card of the qualification examination for primary and secondary school teachers and online marking
Ouma software (301185) announced on February 25 that the company won the bid for the bidding project package 1 of the designated service provider for scanning the answer card of the qualification examination for primary and secondary school teachers and online marking. The service time is from 2022 to 2024, and the bid winning (transaction) price of the project is 14.4375 million yuan / year, accounting for 9.36% of the company’s audited operating revenue in 2020.
Shanghai Baolong Automotive Corporation(603197) : received the notice of fixed point of ADAS project
Shanghai Baolong Automotive Corporation(603197) (603197) announced on February 25 that an independent brand host factory in China selected the company as the parts supplier of its new platform project 360 HD surround camera. The life cycle of the project is five years, and the total amount of the life cycle is about 146 million yuan. It is expected to start mass production in April 2023.
Tengda Construction Group Co.Ltd(600512) : won the bid for the 479 million yuan project
Tengda Construction Group Co.Ltd(600512) (600512) announced on February 25 that the company was the successful bidder of “civil engineering bid 10 (Yanggao North Road station ~ Dongjing Road station interval, Dongjing Road station and Gaonan River Bridge) of phase I project of Shanghai rail transit line 21”, with a bid price of 479 million yuan.
Nuode Investment Co.Ltd(600110) : Sun signed a lithium battery copper foil product contract
Nuode Investment Co.Ltd(600110) (600110) announced on February 25 that recently, Huizhou electronics, a wholly-owned subsidiary of the company, signed a production pricing agreement with an overseas large automobile enterprise, which agreed that the company and its subsidiaries would supply copper foil products to the cooperative customers and their authorized parties from January 1, 2022. In 2022, the company and its wholly-owned subsidiaries promised their cooperative customers that the total supply of products would not be less than 6930 tons; After January 1, 2023, the company and its subsidiaries guarantee to cooperative customers that the supply of products is not less than 1515 tons per month.
[major investment]
Sinomine Resource Group Co.Ltd(002738) : it is proposed to invest 1 billion yuan to build a high-purity lithium salt project with an annual output of 35000 tons
Sinomine Resource Group Co.Ltd(002738) (002738) announced on February 25 that the company plans to invest in the construction of 35000 tons of high-purity lithium salt project with a total investment of about 1 billion yuan through its wholly-owned company Chunpeng lithium industry.
Zhejiang Orient Gene Biotech Co.Ltd(688298) : it is proposed to invest 500 million yuan in the construction of Dongfang gene international R & D and Innovation Center project
Zhejiang Orient Gene Biotech Co.Ltd(688298) (688298) announced on February 25 that the company plans to sign the investment agreement with the Management Committee of Lingang New Area of China (Shanghai) pilot free trade zone to invest and establish a wholly-owned subsidiary of the company in Shanghai Lingang New Area and invest in the R & D and Innovation Center project of Dongfang gene international, with a total investment of 500 million yuan.
Guangzhou Development Group Incorporated(600098) : the subsidiary signed the investment and development agreement of photovoltaic power generation project
Guangzhou Development Group Incorporated(600098) (600098) announced on February 25 that the wholly-owned subsidiary Guangzhou Development Group Incorporated(600098) new energy company signed the investment and development agreement for 400MW agricultural (forest) photovoltaic power generation project in Xiushan Tujia and Miao Autonomous County with the people’s Government of Xiushan Tujia and Miao Autonomous County, Chongqing on February 24. The Guangzhou Development Group Incorporated(600098) new energy company will build a photovoltaic power generation project in the selected development area in combination with agriculture (or forestry and animal husbandry), with an installed capacity of 400 MW and a total investment of about 1.5 billion yuan.
[M & A]
Chengdu B-Ray Media Co.Ltd(600880) : it is proposed to acquire 76% equity of elite education with RMB 17.5256 million
Chengdu B-Ray Media Co.Ltd(600880) (600880) announced on February 25 that the company plans to acquire 76% equity of elite education in cash of RMB 17.5256 million.
Shandong Sun Paper Co.Ltd(002078) : the subsidiary plans to acquire 100% equity of Liujing Chengquan with 1.5 billion yuan
Shandong Sun Paper Co.Ltd(002078) (002078) announced on February 25 that the wholly-owned subsidiary Nanning Shandong Sun Paper Co.Ltd(002078) plans to acquire 100% equity of Guangxi Liujing Chengquan Investment Co., Ltd. held by Guangxi hongruitai pulp Co., Ltd. for 1.5 billion yuan.
The smooth implementation of the acquisition of the company’s wholly-owned subsidiary will accelerate the implementation progress of the Nanning project of Shandong Sun Paper Co.Ltd(002078) Guangxi base.
[refinancing]
Anhui Estone Materials Technology Co.Ltd(688733) : it is proposed to raise no more than 951 million yuan
Anhui Estone Materials Technology Co.Ltd(688733) (688733) disclosed the plan for non-public offering of A-Shares on February 25. The total amount of funds raised in this offering does not exceed 951 million yuan. After deducting the issuance expenses, it is planned to be used for the construction project of electronic functional powder materials with an annual output of 15000 tons, the construction project of boehmite for coating lithium batteries with an annual output of 20000 tons, the construction project of technology R & D center and supplementary working capital.
Landai Technology Group Corp.Ltd(002765) : it is proposed to raise no more than 600 million yuan
Landai Technology Group Corp.Ltd(002765) (002765) disclosed the plan for non-public offering of A-Shares on February 25. The total amount of funds raised this time does not exceed 600 million yuan, which is used to invest in new energy vehicle high-precision transmission gear and motor shaft manufacturing projects, vehicle mounted and industrial touch screen cover glass expansion projects and supplement working capital.
Pci Technology Group Co.Ltd(600728) : it is proposed to raise no more than 3.314 billion yuan
Pci Technology Group Co.Ltd(600728) (600728) announced on February 25 that it is planned to raise no more than 3.314 billion yuan for the R & D project of digital twin core technology and open platform, the R & D and industrialization project of new generation rail transit digital system, the R & D and industrialization project of new generation transportation digital system for vehicle road coordination, the upgrading and construction project of national sales and service system and supplementary working capital.
Muyuan Foods Co.Ltd(002714) : it is proposed to adjust the fixed increase amount to 5-6 billion yuan
Muyuan Foods Co.Ltd(002714) (002714) announced on February 25 that it is planned to adjust the total amount of fixed increase fund-raising from no more than 6 billion yuan to 5-6 billion yuan.
[other]
Infund Holding Co.Ltd(002141) : the holding subsidiary obtained the veterinary drug production license and veterinary drug GMP certificate
Infund Holding Co.Ltd(002141) (002141) announced on February 25 that Shiji biology, a holding subsidiary, recently received the veterinary drug production license and veterinary drug GMP certificate issued by Sichuan Provincial Department of agriculture and rural areas. The scope of production and acceptance includes: cell suspension culture virus live vaccine, embryo culture virus live vaccine, cell culture virus live vaccine, embryo culture virus inactivated vaccine, cell culture virus inactivated vaccine and bacterial inactivated vaccine (2).
Guangyuyuan Chinese Herbal Medicine Co.Ltd(600771) : temporary suspension of holding subsidiaries affected by the epidemic
Guangyuyuan Chinese Herbal Medicine Co.Ltd(600771) (600771) announced on February 25 that Shanxi Guangyuyuan Chinese Herbal Medicine Co.Ltd(600771) , the core holding subsidiary of the company, is located in Taigu District, Jinzhong City, Shanxi Province. Due to the local epidemic recently, it was temporarily suspended in accordance with the emergency notice on epidemic prevention and control of commercial (industrial) enterprises in the whole region issued by the Bureau of industry and information technology of Taigu District, Jinzhong City. The temporary shutdown has a serious impact on the normal production and operation of Shanxi Guangyuyuan Chinese Herbal Medicine Co.Ltd(600771) , which will delay the completion of production plan and finished product delivery on schedule, and have a certain impact on market supply.
China National Nuclear Power Co.Ltd(601985) : Jiangsu nuclear power unit 8 starts construction
China National Nuclear Power Co.Ltd(601985) (601985) announced on February 25 that Jiangsu nuclear power unit 8 invested by the company had poured the first tank of concrete (FCD) of the nuclear island on February 25, marking the official commencement of the construction of the unit. After the commencement of Jiangsu nuclear power unit 8, the number of units under construction controlled by the company was 7, with an installed capacity of 7.514 million KW.
Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) : sal0114 tablets were approved for clinical trial
Shenzhen Salubris Pharmaceuticals Co.Ltd(002294) (002294) announced on February 25 that the company received the clinical trial approval notice approved and issued by the State Drug Administration and agreed to carry out the clinical trial of sal0114 tablets for Alzheimer’s agitation indications.
